EUVIMEDEUVIMED entdecken
Crossref

Oral Cyclophosphamide Confounds the Relationship between CYP2C19 and CYP2B6 Pharmacogenetics and Cyclophosphamide-induced premature Ovarian Failure in Lupus Nephritis Patients

Nuala Helsby, Michael Goldthorpe, Peter Gow, Janak de Zoysa

Advances in Pharmacology and Pharmacy · 2013

DOI: 10.13189/app.2013.010101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Pharmacology and Pharmacy, 2013. Verfasst von Nuala Helsby und 3 weiteren Autor:innen. Die Arbeit wurde bisher 2-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Helsby, N., Goldthorpe, M., Gow, P., & Zoysa, J. D. (2013). Oral Cyclophosphamide Confounds the Relationship between CYP2C19 and CYP2B6 Pharmacogenetics and Cyclophosphamide-induced premature Ovarian Failure in Lupus Nephritis Patients. Advances in Pharmacology and Pharmacy. https://doi.org/10.13189/app.2013.010101

Vancouver

Helsby N, Goldthorpe M, Gow P, Zoysa JD. Oral Cyclophosphamide Confounds the Relationship between CYP2C19 and CYP2B6 Pharmacogenetics and Cyclophosphamide-induced premature Ovarian Failure in Lupus Nephritis Patients. Advances in Pharmacology and Pharmacy. 2013. doi:10.13189/app.2013.010101

BibTeX
@article{Helsby2013,
  author = {Helsby, Nuala and Goldthorpe, Michael and Gow, Peter and Zoysa, Janak de},
  title = {Oral Cyclophosphamide Confounds the Relationship between CYP2C19 and CYP2B6 Pharmacogenetics and Cyclophosphamide-induced premature Ovarian Failure in Lupus Nephritis Patients},
  journal = {Advances in Pharmacology and Pharmacy},
  year = {2013},
  doi = {10.13189/app.2013.010101}
}
Kostenlos starten →